In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
Commercial Interest
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Faculty and Disclosures
Moderator
Kelly Hunt, MD, FACS – Merck & Co., Medical Advisory Board; Armada Health, Medical Advisory Board; Endomagnetics Lumicell, Study PI; OncoNano, Study PI
Speaker
Matthew Katz, MD, FACS – Nothing to disclose
Planning Committee
Connie Bura – Nothing to disclose
Asa Carter, MBA, CTR – Nothing to disclose
Vicki Chiappetta, RHIA, CTR – Nothing to disclose
Chantel Ellis – Nothing to disclose
Erin DeKoster, JD – Nothing to disclose
Lauren Dyer – Nothing to disclose
Carolyn Jones – Nothing to disclose
Ingrid Katauskas – Nothing to disclose
Susanne Kessler, MSM, RHIT, CTR – Nothing to disclose
Ryan McCabe, PhD – Nothing to disclose
Sue Rubin – Nothing to disclose
Andrea Scrementi – Nothing to disclose
Karen Stachon – Nothing to disclose
